These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6391938)

  • 1. Insulin suppressive effects of aminotetralin analogs and of dopamine.
    Blum JW
    Eur J Pharmacol; 1984 Oct; 105(3-4):239-44. PubMed ID: 6391938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone responses to the dopaminergic agonist 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
    Blum JW; Fischer JA
    Life Sci; 1984 Oct; 35(14):1469-74. PubMed ID: 6482667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    Kohli JD; Goldberg LI; McDermed JD
    Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic suppression of pancreatic somatostatin secretion.
    Itoh M; Furman BL; Gerich JE
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):56-61. PubMed ID: 6126981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
    Atkinson RL; Dahms WT; Bray GA; Sperling MA
    Horm Metab Res; 1981 May; 13(5):249-53. PubMed ID: 7021385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism.
    Cyrus J; Stagner J; Samols E
    Endocrinology; 1982 Jul; 111(1):214-8. PubMed ID: 6123430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of clonidine on plasma insulin level in mice (author's transl)].
    Ozawa H; Goto M; Takahashi M; Uematsu Y
    Nihon Yakurigaku Zasshi; 1978 Apr; 74(3):383-8. PubMed ID: 669483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
    Hoffmann IS; Naylor RJ; Cubeddu LX
    J Pharmacol Exp Ther; 1980 Nov; 215(2):486-93. PubMed ID: 7441511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic modulation of pancreatic hormone secretion in utero: studies in fetal sheep.
    Sperling MA; Christensen RA; Ganguli S; Anand R
    Pediatr Res; 1980 Mar; 14(3):203-8. PubMed ID: 6992082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):685-92. PubMed ID: 1237422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an original piperazine derivative of tetraline on the adrenergically mediated metabolic responses in cats and rats.
    Bogoslovova T; Staneva-Stoytcheva D
    Acta Physiol Pharmacol Bulg; 1988; 14(4):55-64. PubMed ID: 2907712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the adrenergic beta-receptor-mediated insulin secretion in pertussis-sensitized rats.
    Sumi T; Ui M
    Endocrinology; 1975 Aug; 97(2):352-8. PubMed ID: 1157756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (-)-(R)-1-(p-hydroxyphenyl)-2-[3,4-dimethoxyphenethyl)amino]ethanol (TA-064), a new cardiotonic agent, on circulating parameters of carbohydrate and lipid metabolism in the rat.
    Inamasu M; Totsuka T; Morita T; Takeyama S
    Biochem Pharmacol; 1984 Jul; 33(14):2171-7. PubMed ID: 6147139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A receptor mechanism for the inhibition of insulin release by epinephrine in man.
    Porte D
    J Clin Invest; 1967 Jan; 46(1):86-94. PubMed ID: 6018752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.
    Iversen J
    J Clin Invest; 1973 Sep; 52(9):2102-16. PubMed ID: 4727451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of adrenergic blocking agents on the acute tolbutamide response in dogs].
    Sirek A; Sirek OV; Smigura F; Przybylska K
    Acta Diabetol Lat; 1970; 7(5):777-88. PubMed ID: 4404338
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide.
    Pfeifer MA; Halter JB; Graf R; Porte D
    Diabetes; 1980 May; 29(5):335-40. PubMed ID: 6991327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
    Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.